Belantamab mafodotin Antibody
Belantamab mafodotin (GSK2857916) is a BCMA-targeting antibody-drug conjugate for multiple myeloma research. It promotes immune cell activity within tumors and inhibits tumor progression, making it applicable for both in vitro mechanistic studies and in vivo xenograft models of hematological malignancies.
Product Specifications
Product Name Alternative
ADCs, AntibodyDrugConjugates (ADCs), AntibodyDrugConjugates, AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates, Belantamab mafodotin, Belantamab mafodotin-blm, GSK2857916, GSK-2857916, GSK 2857916
Target
Antibody-Drug Conjugates (ADCs)
Conjugation
Unconjugated
Concentration
7.98 mg/mL
Purity
99.10% (May vary between batches)
Molecular Weight
146.06 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471902-500 1x 500 µL
Nucleophosmin (Acute Myeloid Leukemia Marker) (NPM1/1902), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401578-100 1x 100 µL
SREBP1 (SREBP1/1578), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 